search
Back to results

Allopurinol in Acute Gout

Primary Purpose

Gout

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
allopurinol
Sponsored by
Université de Sherbrooke
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gout focused on measuring Gout, uric acid, allopurinol

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

More than 18 years old Able to sign informed consent Indication of long-term treatment with allopurinol Acute gout crisis

Exclusion Criteria:

Les than 18 years-old Unable to consent Contra-indication to allopurinol

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    Allopurinol

    placebo

    Arm Description

    treatment with allopurinol

    placebo comparator

    Outcomes

    Primary Outcome Measures

    Duration of the gout crises
    Presence of inflammatory signs

    Secondary Outcome Measures

    Full Information

    First Posted
    January 21, 2013
    Last Updated
    May 10, 2017
    Sponsor
    Université de Sherbrooke
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01775098
    Brief Title
    Allopurinol in Acute Gout
    Official Title
    Allopurinol in Acute Gout The Title Will Not be Change as the Study as Been Closed.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2017
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    because of a lack of funding
    Study Start Date
    undefined (undefined)
    Primary Completion Date
    December 2012 (Actual)
    Study Completion Date
    February 2013 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Université de Sherbrooke

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Gout
    Keywords
    Gout, uric acid, allopurinol

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Allopurinol
    Arm Type
    Experimental
    Arm Description
    treatment with allopurinol
    Arm Title
    placebo
    Arm Type
    Placebo Comparator
    Arm Description
    placebo comparator
    Intervention Type
    Drug
    Intervention Name(s)
    allopurinol
    Intervention Description
    No arms will not be change as the study as been closed.
    Primary Outcome Measure Information:
    Title
    Duration of the gout crises
    Description
    Presence of inflammatory signs
    Time Frame
    First 7 days after visit

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: More than 18 years old Able to sign informed consent Indication of long-term treatment with allopurinol Acute gout crisis Exclusion Criteria: Les than 18 years-old Unable to consent Contra-indication to allopurinol

    12. IPD Sharing Statement

    Learn more about this trial

    Allopurinol in Acute Gout

    We'll reach out to this number within 24 hrs